Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FE7B1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,464
Award facts
- Contract value 100% obligated
- $55,464.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an award value of $55,464.36 and an ultimate completion date of February 18, 2025. The contract is not associated with a set-aside designation.
The contract covers the delivery of Trikafta, a specialty pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense (DoD).
In addition to this delivery order, DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FE7B1?
SPE2DB25FE7B1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 14, 2025.
How much is contract SPE2DB25FE7B1 worth?
The government has obligated $55,464 on SPE2DB25FE7B1.
Is contract SPE2DB25FE7B1 an order under another contract?
Yes. SPE2DB25FE7B1 is a delivery order under SPE2DB20D9103, an indefinite delivery contract.
Was contract SPE2DB25FE7B1 competed?
The extent of competition for SPE2DB25FE7B1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award